BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bays H. Adiposopathy, “sick fat,” Ockham’s razor, and resolution of the obesity paradox. Curr Atheroscler Rep. 2014;16:409. [PMID: 24659222 DOI: 10.1007/s11883-014-0409-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Oshakbayev K, Dukenbayeva B, Otarbayev N, Togizbayeva G, Tabynbayev N, Gazaliyeva M, Idrisov A, Oshakbayev P. Weight loss therapy for clinical management of patients with some atherosclerotic diseases: a randomized clinical trial. Nutr J 2015;14:120. [PMID: 26608649 DOI: 10.1186/s12937-015-0108-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Bays HE, Jones PH, Jacobson TA, Cohen DE, Orringer CE, Kothari S, Azagury DE, Morton J, Nguyen NT, Westman EC, Horn DB, Scinta W, Primack C. Lipids and bariatric procedures part 1 of 2: Scientific statement from the National Lipid Association, American Society for Metabolic and Bariatric Surgery, and Obesity Medicine Association: EXECUTIVE SUMMARY. Journal of Clinical Lipidology 2016;10:15-32. [DOI: 10.1016/j.jacl.2015.12.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
3 Bays HE, Jones PH, Jacobson TA, Cohen DE, Orringer CE, Kothari S, Azagury DE, Morton J, Nguyen NT, Westman EC, Horn DB, Scinta W, Primack C. Lipids and bariatric procedures part 1 of 2: Scientific statement from the National Lipid Association, American Society for Metabolic and Bariatric Surgery, and Obesity Medicine Association: FULL REPORT. Journal of Clinical Lipidology 2016;10:33-57. [DOI: 10.1016/j.jacl.2015.12.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
4 Scinta W, Bayes H, Smith N. Insulin Resistance and Hunger in Childhood Obesity: A Patient and Physician's Perspective. Adv Ther 2017;34:2386-91. [PMID: 28884449 DOI: 10.1007/s12325-017-0606-8] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Machado MV, Cortez-Pinto H. Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. Int J Mol Sci. 2016;17:481. [PMID: 27043550 DOI: 10.3390/ijms17040481] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 8.8] [Reference Citation Analysis]
6 Mitić N, Popović L. Assessment of the risk status of diseases associated with overweight in students of the University of Pristina - Kosovska Mitrovica. Praxis medica 2019;48:5-12. [DOI: 10.5937/pramed1904005m] [Reference Citation Analysis]
7 Vargas D, López C, Acero E, Benitez E, Wintaco A, Camacho J, Carreño M, Umaña J, Jimenez D, Díaz S, Lizcano F. Thermogenic capacity of human periaortic adipose tissue is transformed by body weight. PLoS One 2018;13:e0194269. [PMID: 29554135 DOI: 10.1371/journal.pone.0194269] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
8 Chi Y, Li J, Li N, Chen Z, Ma L, Peng W, Pan X, Li M, Yu W, He X, Geng B, Cui Q, Liu Y, Yang J. FAM3A enhances adipogenesis of 3T3-L1 preadipocytes via activation of ATP-P2 receptor-Akt signaling pathway. Oncotarget 2017;8:45862-73. [PMID: 28515350 DOI: 10.18632/oncotarget.17578] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
9 Rocha G, Villalobos E, Fuentes C, Villarroel P, Reyes M, Díaz X, Mattar P, Cifuentes M. Preadipocyte proliferation is elevated by calcium sensing receptor activation. Mol Cell Endocrinol 2015;412:251-6. [PMID: 25986659 DOI: 10.1016/j.mce.2015.05.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
10 Bays HE. Ten things to know about ten cardiovascular disease risk factors ("ASPC Top Ten - 2020"). Am J Prev Cardiol 2020;1:100003. [PMID: 34327447 DOI: 10.1016/j.ajpc.2020.100003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Bays HE, Ballantyne CM, Braeckman RA, Stirtan WG, Doyle RT Jr, Philip S, Soni PN, Juliano RA. Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester): Effects Upon High-Sensitivity C-Reactive Protein and Lipid Parameters in Patients With Metabolic Syndrome. Metab Syndr Relat Disord 2015;13:239-47. [PMID: 25893544 DOI: 10.1089/met.2014.0137] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
12 Liu DM, Jiang LD, Gan L, Su Y, Li F. ASSOCIATION BETWEEN SERUM URIC ACID LEVEL AND BODY MASS INDEX IN SEX- AND AGE-SPECIFIC GROUPS IN SOUTHWESTERN CHINA. Endocr Pract 2019;25:438-45. [PMID: 30657365 DOI: 10.4158/EP-2018-0426] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
13 Yue HQ, Zhou YH, Guo Y, Tang CY, Wang F, Zhou HD. Serum miR-503 is a Candidate Biomarker for Differentiating Metabolic Healthy Obesity from Metabolic Unhealthy Obesity. Diabetes Metab Syndr Obes. 2020;13:2667-2676. [PMID: 32821139 DOI: 10.2147/dmso.s262888] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 De Lorenzo A, Soldati L, Sarlo F, Calvani M, Di Lorenzo N, Di Renzo L. New obesity classification criteria as a tool for bariatric surgery indication. World J Gastroenterol 2016; 22(2): 681-703 [PMID: 26811617 DOI: 10.3748/wjg.v22.i2.681] [Cited by in CrossRef: 106] [Cited by in F6Publishing: 86] [Article Influence: 17.7] [Reference Citation Analysis]
15 Gonçalves N, Silva AF, Rodrigues PG, Correia E, Moura C, Eloy C, Roncon-albuquerque R, Falcão-pires I, Leite-moreira AF. Early cardiac changes induced by a hypercaloric Western-type diet in “subclinical” obesity. American Journal of Physiology-Heart and Circulatory Physiology 2016;310:H655-66. [DOI: 10.1152/ajpheart.00684.2015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
16 Bays H, Pi-Sunyer X, Hemmingsson JU, Claudius B, Jensen CB, Van Gaal L. Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effects. Curr Med Res Opin 2017;33:225-9. [PMID: 27817208 DOI: 10.1080/03007995.2016.1251892] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
17 Bays HE, Jones PH, Orringer CE, Brown WV, Jacobson TA. National Lipid Association Annual Summary of Clinical Lipidology 2016. J Clin Lipidol 2016;10:S1-43. [PMID: 26891998 DOI: 10.1016/j.jacl.2015.08.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 54] [Article Influence: 11.0] [Reference Citation Analysis]
18 Franssen WMA, Massa G, O Eijnde B, Dendale P, Hansen D, Verboven K. Aberrant Mechanical Efficiency during Exercise Relates to Metabolic Health and Exercise Intolerance in Adolescents with Obesity. Int J Environ Res Public Health 2021;18:10578. [PMID: 34682324 DOI: 10.3390/ijerph182010578] [Reference Citation Analysis]
19 Gaggini M, Carli F, Gastaldelli A. The color of fat and its central role in the development and progression of metabolic diseases. Horm Mol Biol Clin Investig 2017;31:/j/hmbci. [PMID: 28942436 DOI: 10.1515/hmbci-2017-0060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
20 Ban RH, Kamvissi V, Schulte KM, Bornstein SR, Rubino F, Graessler J. Lipidomic profiling at the interface of metabolic surgery and cardiovascular disease. Curr Atheroscler Rep 2014;16:455. [PMID: 25236775 DOI: 10.1007/s11883-014-0455-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
21 Betrapally NS, Gillevet PM, Bajaj JS. Gut microbiome and liver disease. Transl Res. 2017;179:49-59. [PMID: 27477080 DOI: 10.1016/j.trsl.2016.07.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 7.2] [Reference Citation Analysis]
22 Idalsoaga F, Kulkarni AV, Mousa OY, Arrese M, Arab JP. Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities. Front Med (Lausanne) 2020;7:448. [PMID: 32974366 DOI: 10.3389/fmed.2020.00448] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
23 Parrettini S, Caroli A, Torlone E. Nutrition and Metabolic Adaptations in Physiological and Complicated Pregnancy: Focus on Obesity and Gestational Diabetes. Front Endocrinol (Lausanne) 2020;11:611929. [PMID: 33424775 DOI: 10.3389/fendo.2020.611929] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Bays HE, Taub PR, Epstein E, Michos ED, Ferraro RA, Bailey AL, Kelli HM, Ferdinand KC, Echols MR, Weintraub H, Bostrom J, Johnson HM, Hoppe KK, Shapiro MD, German CA, Virani SS, Hussain A, Ballantyne CM, Agha AM, Toth PP. Ten things to know about ten cardiovascular disease risk factors. Am J Prev Cardiol 2021;5:100149. [PMID: 34327491 DOI: 10.1016/j.ajpc.2021.100149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
25 Bays H, Perdomo C, Nikonova E, Knoth R, Malhotra M. Lorcaserin and metabolic disease: weight-loss dependent and independent effects. Obes Sci Pract 2018;4:499-505. [PMID: 30574343 DOI: 10.1002/osp4.296] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
26 Owens S, Galloway R. Childhood Obesity and the Metabolic Syndrome. Curr Atheroscler Rep 2014;16. [DOI: 10.1007/s11883-014-0436-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
27 Chan W, Smith B, Stegall M, Borrows R. Obesity and Metabolic Syndrome in Kidney Transplantation: The Role of Dietary Fructose and Systemic Endotoxemia. Transplantation 2019;103:191-201. [PMID: 30130326 DOI: 10.1097/TP.0000000000002424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Su X, Chang D. Role of adiposopathy and physical activity in cardio-metabolic disorder diseases. Clin Chim Acta 2020;511:243-7. [PMID: 33148528 DOI: 10.1016/j.cca.2020.10.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Castro ADAE, Skare TL, Yamauchi FI, Tachibana A, Ribeiro SPP, Fonseca EKUN, Sakuma AT, Peixoto MR, Rodrigues MAS, Barreiros MAM. DIAGNOSTIC VALUE OF C-REACTIVE PROTEIN AND THE INFLUENCE OF VISCERAL FAT IN PATIENTS WITH OBESITY AND ACUTE APPENDICITIS. Arq Bras Cir Dig 2018;31:e1339. [PMID: 29513800 DOI: 10.1590/0102-672020180001e1339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
30 Faulkner JL. Obesity-associated cardiovascular risk in women: hypertension and heart failure. Clin Sci (Lond) 2021;135:1523-44. [PMID: 34160010 DOI: 10.1042/CS20210384] [Reference Citation Analysis]
31 Huth C, Pigeon É, Riou MÈ, St-Onge J, Arguin H, Couillard E, Dubois MJ, Marette A, Tremblay A, Weisnagel SJ, Lacaille M, Mauriège P, Joanisse DR. Fitness, adiposopathy, and adiposity are independent predictors of insulin sensitivity in middle-aged men without diabetes. J Physiol Biochem 2016;72:435-44. [PMID: 27139423 DOI: 10.1007/s13105-016-0488-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
32 Yamauchi FI, Castro ADAE. Obesity, adiposopathy, and quantitative imaging biomarkers. Radiol Bras 2017;50:VII-VIII. [PMID: 28670043 DOI: 10.1590/0100-3984.2017.50.3e2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
33 Gunduz C, Basoglu OK, Hedner J, Bonsignore MR, Hein H, Staats R, Bouloukaki I, Roisman G, Pataka A, Sliwinski P, Ludka O, Pepin JL, Grote L; European Sleep Apnoea Database collaborators. Hyperlipidaemia prevalence and cholesterol control in obstructive sleep apnoea: Data from the European sleep apnea database (ESADA). J Intern Med 2019;286:676-88. [PMID: 31260567 DOI: 10.1111/joim.12952] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
34 Bays HE, Jones PH, Brown WV, Jacobson TA. National Lipid Association Annual Summary of Clinical Lipidology 2015. J Clin Lipidol. 2014;8:S1-S6. [PMID: 25523435 DOI: 10.1016/j.jacl.2014.10.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 6.0] [Reference Citation Analysis]
35 Machado MV, Diehl AM. Pathogenesis of Nonalcoholic Steatohepatitis. Gastroenterology 2016;150:1769-77. [PMID: 26928243 DOI: 10.1053/j.gastro.2016.02.066] [Cited by in Crossref: 169] [Cited by in F6Publishing: 156] [Article Influence: 28.2] [Reference Citation Analysis]
36 Iacobini C, Pugliese G, Blasetti Fantauzzi C, Federici M, Menini S. Metabolically healthy versus metabolically unhealthy obesity. Metabolism 2019;92:51-60. [DOI: 10.1016/j.metabol.2018.11.009] [Cited by in Crossref: 87] [Cited by in F6Publishing: 76] [Article Influence: 29.0] [Reference Citation Analysis]
37 Bays HE, Kulkarni A, German C, Satish P, Iluyomade A, Dudum R, Thakkar A, Rifai MA, Mehta A, Thobani A, Al-saiegh Y, Nelson AJ, Sheth S, Toth PP. Ten Things to Know About Ten Cardiovascular Disease Risk Factors – 2022. American Journal of Preventive Cardiology 2022. [DOI: 10.1016/j.ajpc.2022.100342] [Reference Citation Analysis]
38 Tondt J, Yancy WS, Westman EC. Application of nutrient essentiality criteria to dietary carbohydrates. Nutr Res Rev 2020;33:260-70. [PMID: 32102704 DOI: 10.1017/S0954422420000050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Greuter T, Malhi H, Gores GJ, Shah VH. Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis. JCI Insight 2017;2:95354. [PMID: 28878132 DOI: 10.1172/jci.insight.95354] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
40 Crites S, Joumaa V, Rios JL, Sawatsky A, Hart DA, Reimer RA, Herzog W. Moderate aerobic exercise, but not dietary prebiotic fibre, attenuates losses to mechanical property integrity of tail tendons in a rat model of diet-induced obesity. J Biomech 2021;129:110798. [PMID: 34700144 DOI: 10.1016/j.jbiomech.2021.110798] [Reference Citation Analysis]
41 Avolio E, Gualtieri P, Romano L, Pecorella C, Ferraro S, Palma G, Di Renzo L, De Lorenzo A. Obesity and Body Composition in Man and Woman: Associated Diseases and the New Role of Gut Microbiota. Curr Med Chem 2020;27:216-29. [PMID: 30914014 DOI: 10.2174/0929867326666190326113607] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
42 Bays H, Weiter K, Anderson J. A randomized study of raisins versus alternative snacks on glycemic control and other cardiovascular risk factors in patients with type 2 diabetes mellitus. Phys Sportsmed 2015;43:37-43. [PMID: 25609549 DOI: 10.1080/00913847.2015.998410] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
43 Bays H. Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction. Curr Opin Endocrinol Diabetes Obes. 2014;21:345-351. [PMID: 25106000 DOI: 10.1097/med.0000000000000093] [Cited by in Crossref: 70] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
44 Aldan JT, Jansen C, Speck M, Maaetoft-Udsen K, Cordasco EA, Faiai M, Shimoda LMN, Greineisen WE, Turner H, Stokes AJ. Insulin-induced lipid body accumulation is accompanied by lipid remodelling in model mast cells. Adipocyte 2019;8:265-79. [PMID: 31311389 DOI: 10.1080/21623945.2019.1636624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Castro AD, Skare TL, Nassif PA, Sakuma AK, Barros WH. TENDINOPATHY AND OBESITY. Arq Bras Cir Dig 2016;29Suppl 1:107-10. [PMID: 27683789 DOI: 10.1590/0102-6720201600S10026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
46 Frost PA, Chen S, Rodriguez-Ayala E, Laviada-Molina HA, Vaquera Z, Gaytan-Saucedo JF, Li WH, Haack K, Grayburn PA, Sayers K, Cole SA, Bastarrachea RA. Research methodology for in vivo measurements of resting energy expenditure, daily body temperature, metabolic heat and non-viral tissue-specific gene therapy in baboons. Res Vet Sci 2020;133:136-45. [PMID: 32979746 DOI: 10.1016/j.rvsc.2020.09.020] [Reference Citation Analysis]
47 Bays H, Kothari SN, Azagury DE, Morton JM, Nguyen NT, Jones PH, Jacobson TA, Cohen DE, Orringer C, Westman EC, Horn DB, Scinta W, Primack C. Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA) 1. Surgery for Obesity and Related Diseases 2016;12:468-95. [DOI: 10.1016/j.soard.2016.01.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
48 Hassan MB, Nafakhi H, Al-Mosawi AA. Pericardial fat volume and coronary atherosclerotic markers among body mass index groups. Clin Cardiol 2020;43:993-8. [PMID: 32492245 DOI: 10.1002/clc.23396] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 das Graças Coelho de Souza M, Kraemer-aguiar LG, Bouskela E. Inflammation-induced microvascular dysfunction in obesity – A translational approach. CH 2017;64:645-54. [DOI: 10.3233/ch-168018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]